STAT3 Activates MSK1-mediated Histone H3 Phosphorylation to Promote NFAT Signaling in Gastric Carcinogenesis
Overview
Authors
Affiliations
Epigenetic abnormalities contribute significantly to the development and progression of gastric cancer. However, the underlying regulatory networks from oncogenic signaling pathway to epigenetic dysregulation remain largely unclear. Here we showed that STAT3 signaling, one of the critical links between inflammation and cancer, acted as a control pathway in gastric carcinogenesis. STAT3 aberrantly transactivates the epigenetic kinase mitogen- and stress-activated protein kinase 1 (MSK1), thereby phosphorylating histone H3 serine10 (H3S10) and STAT3 itself during carcinogen-induced gastric tumorigenesis. We further identified the calcium pathway transcription factor NFATc2 as a novel downstream target of the STAT3-MSK1 positive-regulating loop. STAT3 forms a functional complex with MSK1 at the promoter of NFATc2 to promote its transcription in a H3S10 phosphorylation-dependent way, thus affecting NFATc2-related inflammatory pathways in gastric carcinogenesis. Inhibiting the STAT3/MSK1/NFATc2 signaling axis significantly suppressed gastric cancer cell proliferation and xenograft tumor growth, which provides a potential novel approach for gastric carcinogenesis intervention by regulating aberrant epigenetic and transcriptional mechanisms.
Zhang J, Wei X, Xie Y, Peng S, Yang P, Chen Y Oncogene. 2025; .
PMID: 40044982 DOI: 10.1038/s41388-025-03323-1.
Kondratowski S, Cohen D, Deyell R, Sandhu A, Bush J PLoS One. 2024; 19(11):e0309471.
PMID: 39570878 PMC: 11581320. DOI: 10.1371/journal.pone.0309471.
Chen M, Wang T, Tian D, Hai C, Qiu Z Heliyon. 2024; 10(18):e37263.
PMID: 39309860 PMC: 11416542. DOI: 10.1016/j.heliyon.2024.e37263.
The RNA mA reader IGF2BP3 regulates NFAT1/IRF1 axis-mediated anti-tumor activity in gastric cancer.
Ge L, Rui Y, Wang C, Wu Y, Wang H, Wang J Cell Death Dis. 2024; 15(3):192.
PMID: 38448411 PMC: 10917814. DOI: 10.1038/s41419-024-06566-0.
Song P, Li X, Chen S, Gong Y, Zhao J, Jiao Y Cell Prolif. 2024; 57(7):e13619.
PMID: 38444279 PMC: 11216948. DOI: 10.1111/cpr.13619.